An ongoing priority is to drive revenue and profit growth in the medical platform business by expanding pharmaceutical marketing support, digital transformation support for healthcare providers, and the acquisition of new projects and services, centered on the “MR-kun” family of pharmaceutical-industry platforms. This also includes expanding the revenue model, such as through the introduction of performance-based fees.